| 1. |
Robinson J., M.J. Waller, P. Parham, N. de Groot, R. Bontrop, L.J. Kennedy, P. Stoehr & S.G.E. Marsh: IMGT/HLA and IMGT/MHC
– sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res. 31(1) 311–314 (2003).
|
| |
| 2. |
Yewdell J.W., E. Reits & J. Neefjes: Making sense of mass destruction – quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 3(12) 952–961 (2003).
|
| |
| 3. |
Del Guercio M.F., J. Sidney, G. Hermanson, C. Perez, H.M. Grey, R.T. Kubo & A. Sette: Binding of a peptide antigen to multiple
HLA alleles allows definition of an A2-like supertype. J. Immunol. 154(2) 685–693 (1995).
|
| |
| 4. |
Sette A. & J. Sidney: Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50(3–4)201–212 (1999).
|
| |
| 5. |
Sette A. & J. Sidney: HLA supertypes and supermotifs – a functional perspective on HLA polymorphism. Curr. Opin. Immunol. 10(4) 478–482 (1998).
|
| |
| 6. |
Sidney J., S. Southwood, V. Pasquetto & A. Sette: Simultaneous prediction of binding capacity for multiple molecules of the
HLA B44 supertype. J. Immunol.171 (11) 5964–5974 (2003).
|
| |
| 7. |
Chelvanayagam G.: A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities. Immunogenetics 45(1) 15–26 (1996).
|
| |
| 8. |
Zhang C, A. Anderson & C. DeLisi: Structural principles that govern the peptide-binding motifs of class I MHC molecules. J. Mol. Biol. 281(5) 929–947 (1998).
|
| |
| 9. |
Zhao B., A.E.H. Png, E.C. Ren, P.R. Kolatkar, V.S. Mathura, M.K. Sakharkar & P. Kangueane: Compression of functional space
in HLA-A sequence diversity. Hum. Immunol. 64(7) 718–728 (2003).
|
| |
| 10. |
Doytchinova I.A., P. Guan & D.R. Flower: Identifying human MHC supertypes using bioinformatics methods. J. Immunol. 172(7), 4314–4323 (2004).
|
| |
| 11. |
Lund O., M. Nielsen, C. Kesmir, A.G. Petersen, C. Lundegaard, P. Worning, C. Sylvester-Hvid, K. Lamberth, G. Roder, S. Justesen,
S. Buus & S. Brunak: Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55(12), 797–810 (2004).
|
| |
| 12. |
Scognamiglio P., D. Accapezzato, M.A. Casciaro, A. Cacciani, M. Artini, G. Bruno, M.L. Chircu, J. Sidney, S. Southwood, S.
Abrignani, A. Sette & V. Barnaba: Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors.
J. Immunol. 162(11), 6681–6689 (1999).
|
| |
| 13. |
Kawashima I., S.J. Hudson, V. Tsai, S. Southwood, K. Takesako, E. Appella, A. Sette & E. Celis: The multi-epitope approach
for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid
epithelial tumors. Hum. Immunol. 59(1), 1–14 (1998).
|
| |